1-6 of 6
Roger A. Fleischman, MD PhD
Close
Sort by
Journal Articles

Enhancing Anti-Tumor Immunity and Responses to Immune Checkpoint Blockade By Suppressing Interleukin-10 in Chronic Lymphocytic Leukemia

Jacqueline R. Rivas, PhDBS, Sara S. Alhakeem, PhD, Joseph M. Eckenrode, PhD, Yinan Zhang, PhD, James P. Collard, BS, Gerhard C. Hildebrandt, MD, Roger A. Fleischman, MD PhD, Li Chen, PhD, Jon S. Thorson, PhD, Markos Leggas, PhD, Subbarao Bondada, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5486.
https://doi.org/10.1182/blood-2019-127178
Published: 2019
Journal Articles

Socioeconomic Disparities Affect Survival of Classical Hodgkin Lymphoma in a Statewide Cancer Registry Analysis

Zin W. Myint, MD, Runa Shrestha, MBBS, Quan Chen, Bin Huang, Amit Goldberg, MD, Reshma Ramlal, MD, Gregory Monohan, MD, Roger A. Fleischman, MD PhD, Roger H. Herzig, MD, Gerhard Carl Hildebrandt, MD, Hayder Saeed, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4836.
https://doi.org/10.1182/blood-2018-99-110988
Published: 2018
Journal Articles

Changes in Killer-Cell Immunoglobulin-like Receptor (KIR) Expression on NK Cells Following DNA Demethylation By Azacitidine in Relapsed and Refractory Lymphomas

Runa Shrestha, MD, Ahmad Al-Attar, MD, John W Hayslip, MD, Lutz T Charles, MD, Emily Dressler, PhD, Jabbour Hossam, MD, Maryam F Zia, MD, Hayder Saeed, MD, Amit Goldberg, MD, Gregory Monohan, MD, Roger Herzig, MD, Roger A Fleischman, MD, PhD, Gerhard Hildebrandt, MD, Shams A Shakil, MD, PhD
Journal: Blood
Blood (2016) 128 (22): 5296.
https://doi.org/10.1182/blood.V128.22.5296.5296
Published: 2016
Journal Articles

Sustained Remissions after Discontinuation of Ibrutinib in Relapsed/Refractory CLL: A Basis for Reducing Drug Toxicity and Treatment Costs?

Jenna Houranieh, PharmD, Roger A Fleischman, MD, PhD
Journal: Blood
Blood (2016) 128 (22): 5600.
https://doi.org/10.1182/blood.V128.22.5600.5600
Published: 2016
Journal Articles

Ibutinib-Associated Autoimmune Hemolytic Anemia in CLL

Jacob Hodskins, MD, Jenna Houranieh, PharmD, Roger A. Fleischman, MD PhD
Journal: Blood
Blood (2014) 124 (21): 5671.
https://doi.org/10.1182/blood.V124.21.5671.5671
Published: 2014
Journal Articles

A HoxD11 Homeobox Gene Mutation Associated With Congenital Absent Radius But Without The Thrombocytopenia Of The TAR Syndrome Or a HoxA11 Mutation

Roger A. Fleischman, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 4837.
https://doi.org/10.1182/blood.V122.21.4837.4837
Published: 2013